![Galectin Therapeutics Inc](/common/images/company/N_GALT.png)
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in prec... Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.17 | -7.62331838565 | 2.23 | 2.5 | 2 | 717554 | 2.25919872 | CS |
4 | -0.57 | -21.6730038023 | 2.63 | 2.8 | 2 | 275497 | 2.3241069 | CS |
12 | -2.19 | -51.5294117647 | 4.25 | 4.2684 | 2 | 202437 | 2.86133285 | CS |
26 | 0.41 | 24.8484848485 | 1.65 | 4.2684 | 1.59 | 156645 | 2.80985203 | CS |
52 | 0.65 | 46.0992907801 | 1.41 | 4.2684 | 1.35 | 106598 | 2.53435791 | CS |
156 | -1.11 | -35.0157728707 | 3.17 | 4.4 | 1.02 | 274959 | 2.98990226 | CS |
260 | -1.86 | -47.4489795918 | 3.92 | 5.7 | 1.02 | 392808 | 2.98630086 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.